tirzepatide cancer 🚨 A surprising finding from one of world's largest meetings… Researchers presenting at the American Society of Clinical Oncology (ASCO) Annual Meeting analyzed health records from nearly 90,000 patients with chronic Tirzepatide as an innovative treatment

Synjardy is an oral diabetes medicine that combines empagliflozin with metformin in one tablet

Revisiting our GLP-1 Basket

Taking Ozempic, Wegovy or another GLP-1 medication

On the topic of weight loss and consumer engagement in self-care and health at home, we applaud the launch of Tufts Food Is Medicine Institutes National Network of Excellence in collaboration with Kaiser Permanente and other partners (shown in the graphic here)

Ryan OConnor, Professional Truck Driver (US)

The heterogeneous nature of multiple sclerosis (MS) and the unavailability of treatments addressing its intricate network and reversing the disease state is yet an area that needs to be elucidated